Cc1ccccc1NC(=O)c1sc2nc(-c3cc4ccccc4oc3=O)[nH]c(=O)c2c1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?